A commercial stage diagnostics company using artificial intelligence to streamline pathologists’ workflows and generate clinical insights.

The labor intensive and subjective manual analysis of tissue biopsies has been the gold standard for cancer diagnosis and staging for over 40 years.  Paige’s digital pathology platform has the potential to upend this paradigm by using artificial intelligence to improve workflow efficiencies by 75%, score cancerous tissue in an objective fashion, and derive clinical insights through pathological biomarkers. Their unique, best in class machine learning approach and exclusive access to Memorial Sloan Kettering’s >2.5M slide dataset has allowed them to outpace their competition in developing a robust and highly accurate portfolio of cancer diagnostics.